Evidence map›Paper›PMID 39320351›Full record

ArticleThe Journal of cell biology2024

Claudin 7 suppresses invasion and metastasis through repression of a smooth muscle actin program.

Junior J West, Rosela Golloshi, Chae Yun Cho, Yuqian Wang, Parker Stevenson, Genevieve Stein-O'Brien, Elana J Fertig, Andrew J Ewald

Abstract read
In one paragraph

Article in The Journal of cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junior J WestDepartments of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-6083-5665
Rosela GolloshiDepartments of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-5567-6441
Chae Yun ChoDepartments of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0001-7608-486X
Yuqian WangDepartments of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0009-0003-8522-8193
Parker StevensonDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-4208-6426
Genevieve Stein-O'BrienDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA.ORCID 0000-0001-8681-9110
Elana J FertigDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0003-3204-342X
Andrew J EwaldDepartments of Cell Biology, Center for Cell Dynamics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1964-0740

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI WILLIAM George NELSON · 1985 to 2026
$208.6M
Tech Core 2U54CA268083 · NCI · JOHNS HOPKINS UNIVERSITY · PI Andrew Josef Ewald · 2022 to 2026
$10.2M
Biochemistry, Cellular and Molecular Biology Program: JHU BioGREAT (Biomedical Graduate REsiliency & Adaptability Training)T32GM144272 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Takanari Inoue · 2022 to 2026
$5.4M
Mapping the single cell state basis of metastasis in space and timeU01CA284090 · NCI · JOHNS HOPKINS UNIVERSITY · PI Andrew Josef Ewald · 2023 to 2026
$2.7M
Resolving Spatiotemporal Determinants of Cell Specification in Corticogenesis with Latent Space MethodsR00NS122085 · NINDS · JOHNS HOPKINS UNIVERSITY · PI STEIN-O'BRIEN, GENEVIEVE LAUREN · 2023 to 2025
$697k
Black in CancerBreast Cancer Research Foundation BCRF-23-048Burroughs WellcomeCancer MoonshotEmerald FoundationGiovanis Institute for Translational Cell BiologyJayne Koskinas Ted Giovanis FoundationNCI NIH HHS P30 CA006973NCI NIH HHS U01 CA284090NCI NIH HHS U01CA284090NCI NIH HHS U54 CA268083NIGMS NIH HHS T32 GM144272NIGMS NIH HHS T32GM144272NIH HHSNINDS NIH HHS R00 NS122085NINDS NIH HHS R00NS122085
6 · The paper itself

Abstract

Metastasis initiates when cancer cells escape from the primary tumor, which requires changes to intercellular junctions. Claudins are transmembrane proteins that form the tight junction, and their expression is reduced in aggressive breast tumors. However, claudins' roles during breast cancer metastasis remain unclear. We used gain- and loss-of-function genetics in organoids isolated from murine breast cancer models to establish that Cldn7 suppresses invasion and metastasis. Transcriptomic analysis revealed that Cldn7 knockdown induced smooth muscle actin (SMA)-related genes and a broader mesenchymal phenotype. We validated our results in human cell lines, fresh human tumor tissue, bulk RNA-seq, and public single-cell RNA-seq data. We consistently observed an inverse relationship between Cldn7 expression and expression of SMA-related genes. Furthermore, knockdown and overexpression of SMA-related genes demonstrated that they promote breast cancer invasion. Our data reveal that Cldn7 suppresses breast cancer invasion and metastasis through negative regulation of SMA-related and mesenchymal gene expression.

Indexed as

ActinsBreast NeoplasmsClaudinsGene Expression Regulation, NeoplasticNeoplasm InvasivenessAnimalsCell Line, TumorCell MovementFemaleHumansMiceNeoplasm MetastasisActinsClaudinsCLDN7 protein, human

Identifiers

PMID39320351
PMCPMC11450322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.